Current stock page

Financial Data

IRTC Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareMedical - DevicesScore data as of Nov 18, 2026

IRTCiRhythm Technologies, Inc.

Healthcare / Medical - Devices

Low Priority

Relative Laggard

BearishEdge 3/10
$94.87+$5.20 (+5.80%)

Latest quote

  • Momentum
    34
  • Value
    43
  • Quality
    58
  • Risk resilience
    44
  • Sentiment
    —
algovestiq.comScore data as of Nov 18, 2026

Latest Quarter at a Glance

Quarter ended Sep 30, 2026, compared with the same quarter a year earlier.

Revenue
$221.59M
+14.9% YoY
Net income
-$29.85M
−472.7% YoY
Free cash flow
-$11.55M
−157.6% YoY
Operating margin
-14.7%
−12.6 pts YoY

Quarterly Financial Statements

Updated Nov 19, 2026.

IRTC, last 8 quarters. YoY compares the latest quarter with the same quarter a year earlier.

Income statement
Income statement, last 8 quarters, newest first
MetricTrendYoYSep '26Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24
Revenue+14.9%$222M$224M$199M$209M$193M$187M$159M$164M
Gross profit+20.0%$164M$163M$141M$148M$137M$133M$109M$115M
Operating income−713.5%−$33M−$3M−$12M$9M−$4M−$15M−$32M−$4M
Net income−472.7%−$30M−$381K−$14M$6M−$5M−$14M−$31M−$1M
EPS (diluted)−462.5%−$0.90−$0.01−$0.43$0.17−$0.16−$0.44−$0.97−$0.04
Gross margin+3.1 pts74.2%72.8%70.9%70.9%71.1%71.2%68.8%70.0%
Operating margin−12.6 pts-14.7%-1.1%-5.9%4.2%-2.1%-7.8%-20.3%-2.5%
Net margin−10.8 pts-13.5%-0.2%-7.0%2.7%-2.7%-7.6%-19.3%-0.8%
Cash flow
Cash flow, last 8 quarters, newest first
MetricTrendYoYSep '26Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24
Operating cash flow−87.3%$4M$51M−$26M$26M$35M$28M−$8M$19M
Capital expenditure−7.8%−$16M−$14M−$7M−$12M−$15M−$10M−$9M−$7M
Free cash flow−157.6%−$12M$38M−$33M$14M$20M$17M−$17M$12M
Free cash flow margin−15.6 pts-5.2%16.7%-16.6%6.9%10.4%9.3%-10.9%7.5%
Balance sheet
Balance sheet, last 8 quarters, newest first
MetricTrendYoYSep '26Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24
Total assets+9.7%$1.09B$1.09B$1.01B$1.02B$995M$964M$926M$931M
Total liabilities+4.7%$914M$907M$845M$867M$873M$860M$839M$841M
Shareholders' equity+45.3%$177M$186M$161M$153M$122M$104M$87M$91M
Total debt−1.0%$726M$727M$729M$731M$733M$735M$736M$737M
Cash and equivalents+54.4%$395M$247M$240M$236M$256M$309M$375M$420M
Valuation and ratios
Valuation and ratios, last 8 quarters, newest first
MetricTrendYoYSep '26Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24
P/B ratio−31.7316.8622.6626.0434.6748.5943.2639.5838.85
Return on equity+20.4 pts-21.8%-7.5%-17.2%-29.2%-42.2%-89.2%-113.5%-124.6%
Debt to equity−1.924.103.914.524.796.017.098.498.11
Free cash flow yield−0.3 pts0.2%0.9%0.4%0.7%0.5%0.6%0.4%-0.9%

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
MetricValue
P/E ratio-76.64x
P/B ratio16.76x
Revenue growth (YoY)14.88%
EPS growth (YoY)-462.50%
Gross margin72.26%
Operating margin-4.47%
ROE-22.80%
ROIC-4.23%
Debt to equity4.1
FCF yield0.25%

As of Nov 18, 2026

Technical indicators
MetricValue
Close
As of Nov 18, 2026
$94.87
Volume
As of Nov 13, 2026
917,822
RSI (14)
As of Nov 13, 2026
35.33
MACD
As of Nov 13, 2026
-5.89
MACD signal
As of Nov 13, 2026
-2.04
MACD histogram
As of Nov 13, 2026
-3.84
ADX (14)
As of Nov 13, 2026
32
SMA (50)
As of Nov 13, 2026
$111.76
SMA (200)
As of Nov 13, 2026
$119.60
ATR (14)
As of Nov 13, 2026
$7.01
Historical volatility (annualized)
As of Nov 13, 2026
121.46%
Volume (20-day average)
As of Nov 13, 2026
1.01M
Risk measures
MetricValue
Resilience score44/100
Beta0.5
Annual volatility54.02%
Max drawdown-54.53%
Sharpe ratio-0.91
VaR (95%, 1-day)-4.91%

As of Nov 18, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

IRTC Financial Data FAQ

What is iRhythm Technologies, Inc.'s revenue?

iRhythm Technologies, Inc.'s revenue is one of the core financial data points for IRTC. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is iRhythm Technologies, Inc.'s revenue growing?

Revenue growth shows whether iRhythm Technologies, Inc. is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is IRTC's EPS?

IRTC's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is iRhythm Technologies, Inc.'s net income?

iRhythm Technologies, Inc.'s net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does iRhythm Technologies, Inc. generate?

Free cash flow shows how much cash iRhythm Technologies, Inc. generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does iRhythm Technologies, Inc. have?

Cash and debt help frame IRTC's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.